2 unknown. 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
| Not applicable | 1 | Unknown 1 |
Follow Eyecure Therapeutics Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Research of Human Retinal Pigment Epithelial (HuRPE) Cell Injection on Atrophy of High Myopia Macular Area Human retinal pigment epithelial (HuRPE) cell injection - Degenerative Myopia With Macular Hole | Not applicable | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 9 | 2019-12-01 | 2019-12-27 |
| Treatment of RP and LCA by Primary RPE Transplantation Human primary Retinal Pigment Epithelial (HuRPE) cells - Leber Congenital Amaurosis, Retinitis Pigmentosa | Early Phase 1 | Unknown | Eyecure Therapeutics Inc. | 30 | 2018-08-01 | 2018-08-09 |
Leber Congenital Amaurosis (1) · Retinal Degeneration (1) · Retinitis Pigmentosa (1)
Carboxylesterase (1) · Cell Count (1)
China (1)
Ningli Wang (1)